Merus N.V. (MRUS)
USD 36.92
(-11.53%)
USD 36.92
(-11.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -192.88 Million USD | -43.65% |
| 2022 | -134.27 Million USD | 43.51% |
| 2021 | -237.68 Million USD | -49.37% |
| 2020 | -159.12 Million USD | 17.28% |
| 2019 | -192.36 Million USD | -16.98% |
| 2018 | -164.43 Million EUR | 8.43% |
| 2017 | -179.56 Million EUR | -202.57% |
| 2016 | -59.34 Million EUR | -68.59% |
| 2015 | -35.2 Million EUR | -2732.57% |
| 2014 | -1.24 Million EUR | 90.68% |
| 2013 | -13.34 Million EUR | -113.24% |
| 2012 | -6.25 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -431.23 Million USD | 30.27% |
| 2024 Q1 | -166.64 Million USD | 13.61% |
| 2024 Q2 | -618.45 Million USD | -271.13% |
| 2023 Q3 | -229.75 Million USD | -160.15% |
| 2023 FY | -192.88 Million USD | -43.65% |
| 2023 Q2 | -88.31 Million USD | 1.28% |
| 2023 Q4 | -192.88 Million USD | 16.05% |
| 2023 Q1 | -89.45 Million USD | 33.38% |
| 2022 Q3 | -177.83 Million USD | 11.22% |
| 2022 Q1 | -191.21 Million USD | 19.55% |
| 2022 FY | -134.27 Million USD | 43.51% |
| 2022 Q4 | -134.27 Million USD | 24.5% |
| 2022 Q2 | -200.3 Million USD | -4.76% |
| 2021 Q4 | -237.68 Million USD | -53.38% |
| 2021 Q2 | -306.67 Million USD | 5.23% |
| 2021 FY | -237.68 Million USD | -49.37% |
| 2021 Q1 | -323.61 Million USD | -103.36% |
| 2021 Q3 | -154.96 Million USD | 49.47% |
| 2020 Q3 | -134.9 Million USD | 8.55% |
| 2020 FY | -159.12 Million USD | 17.28% |
| 2020 Q2 | -147.51 Million USD | 8.33% |
| 2020 Q4 | -159.12 Million USD | -17.95% |
| 2020 Q1 | -160.92 Million USD | 16.34% |
| 2019 Q1 | -155.78 Million EUR | 4.32% |
| 2019 Q2 | -148.44 Million EUR | 4.71% |
| 2019 Q4 | -192.36 Million USD | -44.12% |
| 2019 Q3 | -133.46 Million EUR | 10.09% |
| 2019 FY | -192.36 Million USD | -16.98% |
| 2018 Q3 | -166.01 Million EUR | 15.7% |
| 2018 Q4 | -162.81 Million EUR | 1.92% |
| 2018 Q2 | -196.93 Million EUR | 2.89% |
| 2018 FY | -164.43 Million EUR | 8.43% |
| 2018 Q1 | -202.8 Million EUR | -12.94% |
| 2017 FY | -179.56 Million EUR | -202.57% |
| 2017 Q1 | -252.74 Million EUR | -325.86% |
| 2017 Q2 | -246.84 Million EUR | 2.33% |
| 2017 Q3 | -237.67 Million EUR | 3.71% |
| 2017 Q4 | -179.56 Million EUR | 24.45% |
| 2016 Q3 | -73.74 Million EUR | 6.05% |
| 2016 FY | -59.34 Million EUR | -68.59% |
| 2016 Q2 | -78.49 Million EUR | -171.3% |
| 2016 Q1 | -28.93 Million EUR | 17.81% |
| 2016 Q4 | -59.34 Million EUR | 19.52% |
| 2015 Q1 | 1.56 Million USD | 226.17% |
| 2015 Q3 | -44.32 Million EUR | -2330.27% |
| 2015 Q4 | -35.2 Million EUR | 20.58% |
| 2015 FY | -35.2 Million EUR | -2732.57% |
| 2015 Q2 | 1.98 Million EUR | 26.75% |
| 2014 FY | -1.24 Million EUR | 90.68% |
| 2014 Q4 | -1.24 Million EUR | 0.0% |
| 2013 FY | -13.34 Million EUR | -113.24% |
| 2012 FY | -6.25 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -244.805% |
| Alkermes plc | -166.73 Million USD | -15.68% |
| Agenus Inc. | 274.13 Million USD | 170.361% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.315% |
| Aptorum Group Limited | 1.35 Million USD | 14313.52% |
| Ardelyx, Inc. | 34.51 Million USD | 658.89% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4606.636% |
| Bicycle Therapeutics plc | -481.46 Million USD | 59.938% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 633.374% |
| ChromaDex Corporation | -24.04 Million USD | -702.079% |
| Chimerix, Inc. | -25.51 Million USD | -655.904% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2868.11% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -714.647% |
| CRISPR Therapeutics AG | -150.84 Million USD | -27.869% |
| Precision BioSciences, Inc. | -85.41 Million USD | -125.833% |
| Dyadic International, Inc. | -6.37 Million USD | -2924.161% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1110.594% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2616.425% |
| Lantern Pharma Inc. | -21.7 Million USD | -788.732% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -74.497% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2157.755% |
| Incyte Corporation | -3.17 Billion USD | 93.925% |
| IO Biotech, Inc. | -140.69 Million USD | -37.09% |
| Jaguar Health, Inc. | 29.39 Million USD | 756.269% |
| Novavax, Inc. | -298.29 Million USD | 35.338% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3714.09% |
| Opthea Limited | 28.15 Million USD | 785.02% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1048.871% |
| ContextLogic Inc. | -232 Million USD | 16.86% |
| MiMedx Group, Inc. | -33.9 Million USD | -468.963% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1991.947% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8224.633% |
| NextCure, Inc. | -6.47 Million USD | -2877.984% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -281.941% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2923.734% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1685.791% |
| Vaxcyte, Inc. | -368.22 Million USD | 47.618% |
| PDS Biotechnology Corporation | -32.7 Million USD | -489.699% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1216.356% |
| Pharming Group N.V. | 109.8 Million USD | 275.662% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1008.784% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -10.075% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -941.498% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -941.498% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2616.676% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3191.536% |
| Acelyrin, Inc. | -216.9 Million USD | 11.074% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3338.054% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -11088.167% |
| Summit Therapeutics Inc. | 34.67 Million USD | 656.278% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2735.279% |
| Senti Biosciences, Inc. | 1.74 Million USD | 11185.287% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -4.484% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -149.04% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3081.854% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 193430.594% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 30814.013% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -64.793% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -14.653% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 273.973% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2439.284% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -49.39% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2897.611% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 20.415% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1001.578% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 39.096% |
| MEI Pharma, Inc. | -3.7 Million USD | -5106.046% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1641.715% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 219.254% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 794.002% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2616.425% |
| Precigen, Inc. | -481 Thousand USD | -40000.624% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1469.817% |
| AlloVir, Inc. | -62.69 Million USD | -207.669% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -246.826% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 412.788% |
| ImmuCell Corporation | 10.99 Million USD | 1854.997% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -25.131% |
| Onconetix, Inc. | 5.33 Million USD | 3717.861% |
| PureTech Health plc | -167.19 Million USD | -15.363% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -533.237% |
| Elevation Oncology, Inc. | -19.11 Million USD | -908.913% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3829.191% |
| Seer, Inc. | -4.24 Million USD | -4449.151% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -702.446% |
| Innoviva, Inc. | 255.56 Million USD | 175.474% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -245.274% |
| ESSA Pharma Inc. | -33.62 Million USD | -473.691% |
| GlycoMimetics, Inc. | -40.98 Million USD | -370.628% |
| GT Biopharma, Inc. | -1.02 Million USD | -18791.675% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -184.561% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 414.877% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -43.858% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1292.061% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -568.066% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -255938.442% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -524.989% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2253.72% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6064.362% |
| Soligenix, Inc. | -4.95 Million USD | -3795.39% |
| Century Therapeutics, Inc. | 847 Thousand USD | 22872.609% |
| Kura Oncology, Inc. | -20.11 Million USD | -858.763% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -371.299% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2196.785% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 10688.161% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5933.281% |
| Autolus Therapeutics plc | -186.59 Million USD | -3.368% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -291.214% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 30.062% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 662.869% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 217.349% |
| GRI Bio, Inc. | -1.79 Million USD | -10651.616% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2047.2% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -479.98% |
| IGM Biosciences, Inc. | -72.6 Million USD | -165.658% |
| INmune Bio, Inc. | -25.41 Million USD | -659.057% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 227.779% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -280.75% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1087.024% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6585.925% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 607.389% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -368.336% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 704.936% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 151.034% |
| Verastem, Inc. | -37.27 Million USD | -417.42% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2025.912% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -271.918% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1174.424% |
| Histogen Inc. | -7.48 Million USD | -2476.252% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -792.7% |
| Surrozen, Inc. | -32.66 Million USD | -490.509% |
| Organovo Holdings, Inc. | -1.5 Million USD | -12699.204% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4488.665% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1117.31% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7473.242% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4741.097% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2201.403% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -344.003% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1223.221% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 39.113% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -26613.016% |
| Apollomics, Inc. | -27.39 Million USD | -604.085% |
| Amarin Corporation plc | -191.04 Million USD | -0.965% |
| Mesoblast Limited | 55.96 Million USD | 444.663% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1222.573% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -662.628% |
| Synaptogenix, Inc. | -28.66 Million USD | -572.973% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -20507.265% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 495.806% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22274.024% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2554.581% |
| Exelixis, Inc. | -73.05 Million USD | -164.044% |
| Better Therapeutics, Inc. | -860 Thousand USD | -22328.372% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -703.248% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 20.088% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 26304.715% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2493.177% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 15481.499% |
| Gritstone bio, Inc. | 39.49 Million USD | 588.438% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -129.348% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7228.03% |
| Avid Bioservices, Inc. | 169.72 Million USD | 213.643% |
| Insmed Incorporated | 721.62 Million USD | 126.729% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2009.979% |
| MediWound Ltd. | -5.32 Million USD | -3524.277% |
| OmniAb, Inc. | 9.2 Million USD | 2195.882% |
| Alector, Inc. | -35.63 Million USD | -441.246% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 324.359% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3814.042% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1556.938% |
| Zai Lab Limited | -775 Million USD | 75.112% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 156.638% |
| Aura Biosciences, Inc. | -21.52 Million USD | -796.093% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -133.855% |
| Immunic, Inc. | -45.34 Million USD | -325.417% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 0.171% |
| Veracyte, Inc. | -203.82 Million USD | 5.367% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 130.219% |
| FibroGen, Inc. | 56.76 Million USD | 439.782% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2266.019% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6722.724% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9216.501% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.202% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5673.242% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -16.22% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1179.857% |
| Galecto, Inc. | -21.21 Million USD | -809.144% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -710.948% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 112.29% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -688.182% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1576.232% |
| XBiotech Inc. | -200.02 Million USD | 3.569% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -129.348% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4359.806% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -446.987% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -149.791% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3489.281% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -13.185% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -108.808% |
| Vaxxinity, Inc. | 10.13 Million USD | 2003.711% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 126.198% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1691.345% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -192.443% |
| NexImmune, Inc. | -3.13 Million USD | -6055.264% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5486.512% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1176.41% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -611.749% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2048.873% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -154733.634% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -375.412% |
| Ainos, Inc. | 4.07 Million USD | 4829.951% |
| Pluri Inc. | 22.82 Million USD | 944.908% |
| Prothena Corporation plc | -608.34 Million USD | 68.294% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -62.42% |
| Celularity Inc. | 65.19 Million USD | 395.88% |
| Rallybio Corporation | -24.1 Million USD | -700.282% |
| Cue Biopharma, Inc. | -33.81 Million USD | -470.342% |
| MeiraGTx Holdings plc | -40.3 Million USD | -378.597% |
| Omeros Corporation | 331.17 Million USD | 158.242% |
| Humacyte, Inc. | -22.48 Million USD | -757.796% |
| Immunocore Holdings plc | -358.59 Million USD | 46.211% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -684.879% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -524.2% |
| Blueprint Medicines Corporation | 702.83 Million USD | 127.444% |
| CalciMedica, Inc. | -5.53 Million USD | -3387.957% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -2.478% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1788.428% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -381.764% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -480.05% |
| Pulmatrix, Inc. | -10.41 Million USD | -1751.627% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3127.104% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -405.7% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -73.142% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -221.774% |
| Cytokinetics, Incorporated | 642.37 Million USD | 130.027% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3212.451% |
| Nutriband Inc. | -251.65 Thousand USD | -76545.593% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -465.327% |
| Vor Biopharma Inc. | 4.3 Million USD | 4585.674% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.804% |
| Evogene Ltd. | -19.63 Million USD | -882.398% |
| ProKidney Corp. | -56.23 Million USD | -242.99% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -296.294% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1988.125% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 114.142% |
| CorMedix Inc. | -43.05 Million USD | -348.02% |
| BioLineRx Ltd. | 7.33 Million USD | 2729.28% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -602.29% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 517.977% |
| Atai Life Sciences N.V. | -28.55 Million USD | -575.411% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 8747.455% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -745.389% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1187.59% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -156.925% |
| MediciNova, Inc. | -50.78 Million USD | -279.816% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -144.761% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -857352.767% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2889.25% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 3.472% |
| Biomea Fusion, Inc. | -166.57 Million USD | -15.798% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -7.771% |
| Mereo BioPharma Group plc | -51.46 Million USD | -274.758% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -103.37% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 34.339% |
| Absci Corporation | -72.59 Million USD | -165.688% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4324.354% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 17.725% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -104.736% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -101.559% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -393.65% |
| Allakos Inc. | -24.97 Million USD | -672.308% |
| Imunon, Inc. | -4.21 Million USD | -4477.38% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1208.398% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -42.455% |
| BioAtla, Inc. | -109.01 Million USD | -76.94% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 26304.715% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -20441.427% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1711.934% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -809.701% |
| XOMA Corporation | -29 Million USD | -565.117% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1064.758% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2039.352% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2489.395% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -54.758% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 7.34% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -135.86% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -107.932% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -22349.673% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4916.489% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11985.217% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 113.968% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16134.182% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4492.712% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 269.97% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 268135.908% |
| Orgenesis Inc. | 21.78 Million USD | 985.439% |
| Entera Bio Ltd. | -10.62 Million USD | -1714.696% |
| GH Research PLC | -78.07 Million USD | -147.043% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -765.416% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -623.523% |
| Xencor, Inc. | 29.64 Million USD | 750.668% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -9692.0% |
| Replimune Group, Inc. | 1.41 Million USD | 13760.34% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -78657.738% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -52.578% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16134.182% |
| Portage Biotech Inc. | -4.98 Million USD | -3772.395% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -857352.767% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -191.709% |
| OncoCyte Corporation | -6.56 Million USD | -2838.961% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 21593.337% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4133.958% |
| Purple Biotech Ltd. | -14.13 Million USD | -1264.295% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -711.938% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2847.044% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1055.536% |
| HilleVax, Inc. | -165.48 Million USD | -16.557% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7499.842% |
| Tharimmune, Inc. | -10.93 Million USD | -1663.857% |
| Genprex, Inc. | -6.73 Million USD | -2762.787% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 47.701% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -118.047% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -13667.595% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5715.108% |
| OKYO Pharma Limited | -826.84 Thousand USD | -23227.625% |
| Savara Inc. | 153 Thousand USD | 126167.974% |
| Curis, Inc. | -23.88 Million USD | -707.485% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3639.576% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -24755.801% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3007.023% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 16377.131% |
| BeiGene, Ltd. | -2.25 Billion USD | 91.439% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1663.269% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 68.286% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -3.932% |
| Erasca, Inc. | -37.21 Million USD | -418.282% |
| bluebird bio, Inc. | 108.57 Million USD | 277.657% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14876.71% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 150.927% |
| DBV Technologies S.A. | -126.98 Million USD | -51.894% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14876.71% |
| Moderna, Inc. | -2.9 Billion USD | 93.365% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1763.253% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1674.788% |
| Molecular Templates, Inc. | 707 Thousand USD | 27382.037% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -514.848% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 155.649% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -135.047% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -110.274% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -497.682% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -461.101% |
| MacroGenics, Inc. | -66.98 Million USD | -187.951% |
| RenovoRx, Inc. | -1.17 Million USD | -16343.649% |
| Adicet Bio, Inc. | -138.78 Million USD | -38.978% |
| Prime Medicine, Inc. | -27.94 Million USD | -590.326% |
| Aditxt, Inc. | 18.12 Million USD | 1164.429% |
| Adagene Inc. | -87.62 Million USD | -120.118% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4530.593% |
| Quantum-Si incorporated | -118.55 Million USD | -62.693% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 635.714% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2480.668% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -297.625% |
| SciSparc Ltd. | -2.06 Million USD | -9240.63% |
| Vericel Corporation | 1.27 Million USD | 15204.464% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1508.479% |
| Minerva Neurosciences, Inc. | 41 Million USD | 570.4% |
| Generation Bio Co. | 31.44 Million USD | 713.343% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -9.991% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -523.756% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 265.434% |
| Invivyd, Inc. | -198.47 Million USD | 2.817% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -113.675% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7944.582% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -172.474% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2726.139% |
| 2seventy bio, Inc. | 181.71 Million USD | 206.146% |
| ADMA Biologics, Inc. | 90.06 Million USD | 314.159% |
| Clene Inc. | 3.34 Million USD | 5874.97% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2023.641% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -796.676% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2889.25% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 43.949% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -641.871% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 208.566% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4614.184% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3956.138% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3602.899% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -48.026% |
| Evaxion Biotech A/S | 5.28 Million USD | 3748.377% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -71.349% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -46.933% |
| Trevena, Inc. | 2.25 Million USD | 8642.25% |
| Surrozen, Inc. | -32.66 Million USD | -490.509% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -274.459% |
| Cingulate Inc. | 3.08 Million USD | 6357.017% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6467.382% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2783.79% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1975.98% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -143.163% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -46.733% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -82.756% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4792.259% |
| Kronos Bio, Inc. | -36.05 Million USD | -434.986% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2149.995% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13328.203% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -255.507% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1437.948% |
| ImmunityBio, Inc. | 618.22 Million USD | 131.2% |
| Korro Bio, Inc. | -132.94 Million USD | -45.088% |
| Kineta, Inc. | -4.54 Million USD | -4147.611% |
| BioVie Inc. | -17.73 Million USD | -987.752% |
| Codexis, Inc. | -43.27 Million USD | -345.758% |
| Celularity Inc. | 65.19 Million USD | 395.88% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5986.589% |
| Celcuity Inc. | 6.78 Million USD | 2943.425% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5632.161% |
| Cibus, Inc. | -8.07 Million USD | -2287.769% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4460.984% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4320.656% |
| IN8bio, Inc. | -16.38 Million USD | -1076.911% |
| Kodiak Sciences Inc. | -103.87 Million USD | -85.689% |
| Annexon, Inc. | -193.75 Million USD | 0.45% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 535888.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1002.257% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5390.578% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 118.295% |
| Eyenovia, Inc. | 1.25 Million USD | 15424.04% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 816.908% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5847.703% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -480.155% |
| Arcellx, Inc. | -296.95 Million USD | 35.047% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -888.844% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -227.616% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -830.593% |
| Moolec Science SA | 117.61 Thousand USD | 164094.695% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -402.315% |
| Geron Corporation | 14.76 Million USD | 1406.714% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -408.687% |
| Royalty Pharma plc | 5.65 Billion USD | 103.409% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -36.39% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2659.655% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3496.664% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -37.059% |
| Humacyte, Inc. | -22.48 Million USD | -757.796% |
| Structure Therapeutics Inc. | -124.33 Million USD | -55.127% |
| 89bio, Inc. | -289.05 Million USD | 33.27% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -664.139% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -10717.947% |
| Genelux Corporation | -6.89 Million USD | -2695.825% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -521.025% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 330.725% |
| Notable Labs, Ltd. | -9.77 Million USD | -1873.036% |
| Liquidia Corporation | -80.17 Million USD | -140.576% |
| Mustang Bio, Inc. | -3.73 Million USD | -5062.848% |
| Immunovant, Inc. | -635.22 Million USD | 69.635% |
| Quantum-Si incorporated | -118.55 Million USD | -62.693% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -998.178% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4555.66% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2502.94% |
| Acasti Pharma Inc. | -23 Million USD | -738.444% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5628.271% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1087.024% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -40.035% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6089.396% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -767.596% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -938.742% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -13.945% |
| PepGen Inc. | -60.67 Million USD | -217.923% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -739.502% |
| United Therapeutics Corporation | -507.7 Million USD | 62.008% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -908.491% |
| Solid Biosciences Inc. | -47.75 Million USD | -303.946% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22274.024% |
| Immuneering Corporation | -54.94 Million USD | -251.063% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4488.665% |
| Silo Pharma, Inc. | -3.52 Million USD | -5372.961% |
| Belite Bio, Inc | -87.27 Million USD | -121.017% |
| XOMA Corporation | -29 Million USD | -565.117% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -172.832% |
| Bionomics Limited | 227 Million USD | 184.967% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -65.876% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7514.844% |
| uniQure N.V. | -102.95 Million USD | -87.355% |
| Cassava Sciences, Inc. | -121.13 Million USD | -59.229% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4530.593% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 571.012% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1512.608% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6133.728% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 182066.038% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5847.703% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2266.019% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2500.917% |
| Altimmune, Inc. | -134.48 Million USD | -43.422% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 197.384% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7514.844% |
| Compugen Ltd. | -12.9 Million USD | -1394.761% |
| Peak Bio, Inc. | 10.34 Million USD | 1965.387% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -68056.89% |
| Benitec Biopharma Inc. | -50.58 Million USD | -281.329% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -84.865% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1081.848% |
| Zura Bio Limited | -99.8 Million USD | -93.259% |
| PolyPid Ltd. | 6.17 Million USD | 3226.159% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 360.232% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1081.848% |
| Instil Bio, Inc. | 75.35 Million USD | 355.957% |
| argenx SE | -2.02 Billion USD | 90.493% |
| Immunome, Inc. | -97.02 Million USD | -98.79% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -757.453% |
| Verona Pharma plc | -220.44 Million USD | 12.502% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -168.854% |
| Shattuck Labs, Inc. | -121.42 Million USD | -58.852% |
| CervoMed Inc. | -7.79 Million USD | -2375.142% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -3.981% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4310.794% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -46.413% |
| Moolec Science SA | 117.61 Thousand USD | 164094.695% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8330.33% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1313.231% |
| AnaptysBio, Inc. | -18.15 Million USD | -962.663% |
| Design Therapeutics, Inc. | -18.15 Million USD | -962.722% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -174.057% |
| NeurAxis, Inc. | 145.7 Thousand USD | 132484.351% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1817.272% |
| Lumos Pharma, Inc. | -28.49 Million USD | -576.952% |
| Achilles Therapeutics plc | -126.92 Million USD | -51.968% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -168.854% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -29315.156% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -828.495% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13328.203% |
| Nutriband Inc. | -251.65 Thousand USD | -76545.593% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1364.46% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2492.527% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 156.698% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 912.656% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 56.895% |
| Palisade Bio, Inc. | -12.06 Million USD | -1498.972% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -37.469% |
| Beam Therapeutics Inc. | -262.72 Million USD | 26.582% |
| Neurogene Inc. | -131.95 Million USD | -46.174% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 984.14% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3852.541% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 48.863% |
| Sesen Bio, Inc. | -112.55 Million USD | -71.372% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -93.154% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8115.545% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -394.245% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -131.603% |
| Athira Pharma, Inc. | -88.99 Million USD | -116.726% |
| Vaccinex, Inc. | -1.28 Million USD | -14875.466% |
| HCW Biologics Inc. | 2.85 Million USD | 6852.043% |
| XOMA Corporation | -29 Million USD | -565.117% |
| Nektar Therapeutics | 210.24 Million USD | 191.745% |
| Arvinas, Inc. | -313.8 Million USD | 38.533% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11985.217% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 421.554% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2680.11% |
| Rezolute, Inc. | -68.16 Million USD | -182.954% |
| Clene Inc. | 3.34 Million USD | 5874.97% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1362.683% |
| BeyondSpring Inc. | -13.75 Million USD | -1302.283% |
| Synlogic, Inc. | -6.68 Million USD | -2785.325% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 17109.171% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2181.301% |
| Peak Bio, Inc. | 10.34 Million USD | 1965.387% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -134.026% |
| Krystal Biotech, Inc. | -350.23 Million USD | 44.927% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 255.395% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -14.135% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6009.446% |
| MannKind Corporation | 143.89 Million USD | 234.041% |
| Ikena Oncology, Inc. | -109.15 Million USD | -76.705% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2447.669% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -482.731% |
| Gossamer Bio, Inc. | 180.35 Million USD | 206.947% |
| CohBar, Inc. | -5.93 Million USD | -3152.28% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -548.393% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4324.354% |
| Legend Biotech Corporation | -949.39 Million USD | 79.684% |
| Mural Oncology plc | -255.84 Million USD | 24.608% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 698.74% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3994.644% |
| Disc Medicine, Inc. | -358.28 Million USD | 46.164% |
| Champions Oncology, Inc. | 4.81 Million USD | 4108.396% |
| REGENXBIO Inc. | 54.76 Million USD | 452.184% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -71628.888% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -27.717% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2040.3% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -139.064% |
| Vaxart, Inc. | -8.24 Million USD | -2240.541% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -284.384% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -51.679% |
| Cellectis S.A. | -43.85 Million USD | -339.822% |
| Longeveron Inc. | -2.9 Million USD | -6532.875% |
| Repare Therapeutics Inc. | -107.85 Million USD | -78.831% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 119.918% |
| Inozyme Pharma, Inc. | 12 Million USD | 1706.831% |
| Revolution Medicines, Inc. | -608.2 Million USD | 68.286% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -15581.626% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 27.246% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -28.528% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1132.722% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -25965.405% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.983% |
| Denali Therapeutics Inc. | -74.86 Million USD | -157.642% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1508.479% |
| Veru Inc. | 4.77 Million USD | 4135.256% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1615.134% |
| Cingulate Inc. | 3.08 Million USD | 6357.017% |
| Passage Bio, Inc. | 4.58 Million USD | 4306.848% |
| Context Therapeutics Inc. | -14.44 Million USD | -1234.853% |
| Exicure, Inc. | 5.84 Million USD | 3397.726% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 16.274% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -387.45% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1329.265% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -227.917% |
| Nuvalent, Inc. | -335.38 Million USD | 42.489% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 11221.458% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -158.967% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2069.674% |
| OmniAb, Inc. | 9.2 Million USD | 2195.882% |
| Anew Medical, Inc. | 1.43 Million USD | 13565.181% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1277.432% |
| Lipocine Inc. | -4.75 Million USD | -3956.794% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -75.624% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1366.391% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -280.75% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 874.883% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2769.871% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -193.017% |
| Ocugen, Inc. | -32.52 Million USD | -493.106% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -125.398% |
| Q32 Bio Inc. | -37.94 Million USD | -408.285% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -30614.013% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1325.708% |
| Equillium, Inc. | -22.39 Million USD | -761.397% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -654.396% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -491.183% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -77702.473% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 243.898% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6131.395% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 58827.138% |
| Dominari Holdings Inc. | 195 Thousand USD | 99014.872% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3562.185% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2063.104% |
| Bio-Techne Corporation | 267.74 Million USD | 172.04% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1089.981% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -63.331% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2195.418% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1424.654% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 21.31% |
| Nkarta, Inc. | 57.29 Million USD | 436.627% |
| BioCardia, Inc. | 212 Thousand USD | 91083.019% |
| Iterum Therapeutics plc | 13.43 Million USD | 1535.362% |